Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Rev Inst Med Trop Sao Paulo ; 55(5): 323-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24037286

RESUMEN

In Brazil, the existing reference values for T-lymphocytes subsets are based on data originated in other countries. There is no local information on normal variation for these parameters in Brazilian adults and children. We evaluated the normal variation found in blood donors from five large Brazilian cities, in different regions, and in children living in Salvador, and Rio de Janeiro. All samples were processed by flow cytometry. The results were analyzed according to region, gender, and lifestyle of blood donors. A total of 641 adults (63% males), and 280 children (58% males) were involved in the study. The absolute CD3+, and CD4+ cells count were significantly higher for females (adults and children). Higher CD4+ cell count in adults was associated with smoking, while higher CD8+ count was found among female children. Higher counts, for all T-cells subsets, were detected in blood donors from southeast / south regions while those living in the northern region had the lowest values. Individuals from midwestern and northeastern regions had an intermediate count for all these cells subsets. However, these differences did not reach statistical significance. In Brazil, gender and smoking, were the main determinants of differences in T-lymphocytes reference values.


Asunto(s)
Subgrupos Linfocitarios/citología , Adulto , Factores de Edad , Donantes de Sangre , Brasil , Niño , Femenino , Citometría de Flujo , Humanos , Inmunofenotipificación , Recuento de Linfocitos , Subgrupos Linfocitarios/inmunología , Masculino , Valores de Referencia
2.
J Virol Methods ; 194(1-2): 132-7, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23994148

RESUMEN

Since 2005, the Department of Sexually Transmitted Diseases (STDs), Acquired Immunodeficiency Syndrome (AIDS) and Viral Hepatitis under the Health Surveillance Secretariat in Brazil's Ministry of Health has approved a testing algorithm for using rapid human immunodeficiency virus (HIV) tests in the country. Given the constant emergence of new rapid HIV tests in the market, it is necessary to maintain an evaluation program for them. Conscious of this need, this multicenter study was conducted to evaluate five commercially available rapid HIV tests used to detect anti-HIV antibodies in Brazil. The five commercial rapid tests under assessment were the VIKIA HIV-1/2 (bioMérieux, Rio de Janeiro, Brazil), the Rapid Check HIV 1 & 2 (Center of Infectious Diseases, Federal University of Espírito Santo, Vitória, Brazil), the HIV-1/2 3.0 Strip Test Bioeasy (S.D., Kyonggi-do, South Korea), the Labtest HIV (Labtest Diagnóstica, Lagoa Santa, Brazil) and the HIV-1/2 Rapid Test Bio-Manguinhos (Oswaldo Cruz Foundation, Rio de Janeiro, Brazil). A total of 972 whole-blood samples were collected from HIV-infected patients, pregnant women and individuals seeking voluntary counselling and testing who were recruited from five centers in different regions of the country. Informed consent was obtained from the study participants. The results were compared with those obtained using the HIV algorithm used currently in Brazil, which includes two enzyme immunoassays and one Western blot test. The operational performance of each assay was also compared to the defined criteria. A total of 972 samples were tested using reference assays, and the results indicated 143 (14.7%) reactive samples and 829 (85.3%) nonreactive samples. Sensitivity values ranged from 99.3 to 100%, and specificity was 100% for all five rapid tests. All of the rapid tests performed well, were easy to perform and yielded high scores in the operational performance analysis. Three tests, however, fulfilled all of the prerequisites established previously by the Department of STDs, AIDS and Viral Hepatitis: the HIV-1/2 3.0 Strip Test Bioeasy, the Rapid Check HIV 1 & 2 and the VIKIA HIV-1/2. Three of the five tests evaluated (the HIV-1/2 3.0 Strip Test Bioeasy, the Rapid Check HIV 1 and 2 and the VIKIA HIV-1/2) performed as well as the reference assays and fulfilled the requirements for use in the Brazilian national algorithm.


Asunto(s)
Técnicas de Laboratorio Clínico/métodos , Pruebas Diagnósticas de Rutina/métodos , Anticuerpos Anti-VIH/sangre , Infecciones por VIH/diagnóstico , Tamizaje Masivo/métodos , Brasil , Femenino , Humanos , Masculino , Embarazo , Sensibilidad y Especificidad
3.
Rev. Inst. Med. Trop. Säo Paulo ; 55(5): 323-328, Sep-Oct/2013. tab
Artículo en Inglés | LILACS | ID: lil-685547

RESUMEN

SUMMARY In Brazil, the existing reference values for T-lymphocytes subsets are based on data originated in other countries. There is no local information on normal variation for these parameters in Brazilian adults and children. We evaluated the normal variation found in blood donors from five large Brazilian cities, in different regions, and in children living in Salvador, and Rio de Janeiro. All samples were processed by flow cytometry. The results were analyzed according to region, gender, and lifestyle of blood donors. A total of 641 adults (63% males), and 280 children (58% males) were involved in the study. The absolute CD3+, and CD4+ cells count were significantly higher for females (adults and children). Higher CD4+ cell count in adults was associated with smoking, while higher CD8+ count was found among female children. Higher counts, for all T-cells subsets, were detected in blood donors from southeast / south regions while those living in the northern region had the lowest values. Individuals from midwestern and northeastern regions had an intermediate count for all these cells subsets. However, these differences did not reach statistical significance. In Brazil, gender and smoking, were the main determinants of differences in T-lymphocytes reference values. .


RESUMO Os valores de referências de linfócitos T existentes no Brasil são baseados em dados originados de outros países. Não existem dados locais da variação normal para estes parâmetros em adultos e crianças brasileiras. Avaliamos a variação normal encontrada em doadores de sangue de cinco grandes cidades brasileiras em diferentes regiões e em crianças residentes em Salvador e Rio de Janeiro. Todas as amostras foram processadas por citometria de fluxo. Os resultados foram analisados de acordo com região, gênero e estilo de vida dos doadores. Um total de 641 adultos (63% homens) e 280 crianças (58% meninos) participaram do estudo. Valores absolutos de CD3+ e CD4+ foram significantemente maiores no gênero feminino (adultos e crianças). Maiores valores de CD4+ em adultos foram associados com tabagismo, enquanto que maiores valores de CD8+ foram encontrados entre crianças do sexo feminino. Adultos das regiões sul e sudeste apresentaram maiores valores absolutos para todas as células T enquanto que adultos da região norte, apresentaram menores valores. Indivíduos residentes no nordeste e centro-oeste obtiveram contagens intermediárias para todas as populações de células T. Entretanto, estas diferenças entre as regiões, não demonstraram diferença estatística. No Brasil, gênero e tabagismo foram os principais determinantes para diferenças em valores de referências de linfócitos T. .


Asunto(s)
Adulto , Niño , Femenino , Humanos , Masculino , Subgrupos Linfocitarios/citología , Factores de Edad , Donantes de Sangre , Brasil , Citometría de Flujo , Inmunofenotipificación , Recuento de Linfocitos , Subgrupos Linfocitarios/inmunología , Valores de Referencia
4.
Sex Transm Dis ; 38(10): 957-61, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21934572

RESUMEN

BACKGROUND: Chlamydia trachomatis (CT) is a sexually transmitted infection having repercussions on reproductive health and impact on the foetus. Our goal was to estimate the prevalence of and risk factors for CT in young parturient women in Brazil. METHODS: A national cross-sectional study of parturient women, aged 15 to 24 years, attending Brazilian public hospitals was performed in 2009. Participants answered a questionnaire including demographic, behavioral, and clinical data. A sample of urine was collected and screened for CT and Neisseria gonorrhoeae (NG), using polymerase chain reaction COBAS Amplicor CT/NG (Roche Molecular Systems, Branchburg, NJ). RESULTS: A total of 2400 women were selected and 2071 (86.3%) participated in the study. Mean age was 20.2 years (standard deviation = 2.7). Prevalence rates of CT and NG were 9.8% (95% confidence interval [CI]: 8.5-11.1) and 1.0% (95% CI: 0.6%-1.4%), respectively. Four percent of women infected with CT also had NG infection. CT associated factors were: being younger (15-19 years old) (odds ratio [OR] = 1.6 [95% CI: 1.15-2.17]); first sexual intercourse before 15 years of age (OR = 1.4 [95% CI: 1.04-6.24]); having more than 1 sexual partner in lifetime (OR = 1.6 [95% CI: 1.13-2.26]); Pap smear screening more than 1 year (OR = 1.5 [95% CI: 1.08-2.05]); and NG infection (OR = 7.6 [95% CI: 3.05-19.08]). CONCLUSIONS: This study shows a high prevalence of CT infection among young pregnant women in Brazil. We suggest that CT screening should be included as part of antenatal care routine in this group in Brazil.


Asunto(s)
Infecciones por Chlamydia/epidemiología , Chlamydia trachomatis/aislamiento & purificación , Gonorrea/epidemiología , Neisseria gonorrhoeae/fisiología , Asunción de Riesgos , Adolescente , Brasil/epidemiología , Infecciones por Chlamydia/prevención & control , Infecciones por Chlamydia/orina , Coinfección/epidemiología , Intervalos de Confianza , Estudios Transversales , Femenino , Gonorrea/prevención & control , Gonorrea/orina , Humanos , Oportunidad Relativa , Embarazo , Complicaciones Infecciosas del Embarazo/prevención & control , Prevalencia , Salud Reproductiva , Conducta Sexual , Parejas Sexuales , Encuestas y Cuestionarios , Adulto Joven
5.
AIDS Res Hum Retroviruses ; 26(3): 265-73, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20210652

RESUMEN

In Brazil, where three distinct HIV-1 subtypes (B, F, and C) cocirculate, a significant portion of the HIV-infected population has been exposed to antiretroviral drugs. This study analyzes the antiretroviral resistance profiles of HIV-1-infected individuals failing antiretroviral therapy. Genotypic resistance profiles of 2474 patients presenting virologic failure to antiretroviral therapy in the city of São Paulo, Brazil, were generated and analyzed. Resistance mutations to protease inhibitors and nucleoside reverse transcriptase inhibitors were less common in subtype C viruses, whereas nonnucleoside reverse transcriptase inhibitor resistance mutations were less common in subtype F viruses. The thymidine analog mutation pathway known as pathway 1 was more prevalent in subtype B viruses than in subtype C viruses, whereas pathway 2 was more prevalent in subtype C viruses. Selected resistance mutations varied according to subtype for all three classes of antiretrovirals. We describe two distinct pathways of nonnucleoside reverse transcriptase inhibitor resistance (to nevirapine and efavirenz). Although cross-resistance to etravirine should occur more frequently among individuals failing nevirapine treatment, the prevalence of cross-resistance to etravirine, darunavir, and tipranavir was found to be low. We found that increases in the number of resistance mutations will be related to increases in the viral load. Special attention should be given to resistance profiles in non-B subtype viruses. The accumulation of knowledge regarding such profiles in the developing world is desirable.


Asunto(s)
Farmacorresistencia Viral Múltiple/genética , Infecciones por VIH/virología , VIH-1/genética , Mutación , Alquinos , Benzoxazinas/uso terapéutico , Brasil/epidemiología , Estudios de Cohortes , Ciclopropanos , Darunavir , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/epidemiología , Inhibidores de la Proteasa del VIH/uso terapéutico , VIH-1/efectos de los fármacos , Humanos , Nevirapina/uso terapéutico , Nitrilos , Piridazinas/uso terapéutico , Piridinas/uso terapéutico , Pirimidinas , Pironas/uso terapéutico , Inhibidores de la Transcriptasa Inversa/uso terapéutico , Sulfonamidas/uso terapéutico , Insuficiencia del Tratamiento , Carga Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...